Health
Novel polyclonal antibody XAV-19 efficiently neutralizes UK and South African SARS-CoV-2 variants – News-Medical.Net
A promising new study reports on the high neutralizing efficacy of a polyclonal swine antibody against SARS-CoV-2, the pathogen responsible for the novel COVID-19….
A promising new study, released as a preprint on the bioRxiv* server, reports on the high neutralizing efficacy of a polyclonal swine antibody against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the novel coronavirus disease 2019 (COVID-19). By demonstrating the ability of this antibody to neutralize all currently circulating viral variants, the study suggests that it is ideal for development as a new and very effective therapy for COVID-19.
Antibodies…
-
Business22 hours ago3 ASX 200 shares set to dominate the next decade
-
Business9 hours ago3 of the best ASX shares to buy with $5,000
-
General22 hours agoWife of missing pilot David Stephens says the experienced pilot had plane recently inspected
-
Noosa News19 hours agoWho was the first PM to visit China? Take the Brisbane Times Quiz